BL
Belite Bio, Inc (BLTE)
NASDAQ·Healthcare·Biotechnology
$159.67
-2.08%
Mkt Cap $6.72B
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 2, 2026 | $16.67M | — | — | -$0.56 | -$0.38 | +32.14% | — | — |
| Q4 2025 Nov 10, 2025 | — | — | — | -$0.53 | -$0.65 | -22.64% | — | — |
| Q3 2025 Aug 11, 2025 | — | — | — | -$0.47 | -$0.50 | -6.38% | — | — |
| Q2 2025 May 13, 2025 | — | — | — | -$0.36 | -$0.45 | -25.00% | — | — |
| Q1 2025 Mar 17, 2025 | — | — | — | -$0.30 | -$0.32 | -6.67% | — | — |
| Q4 2024 Nov 12, 2024 | — | — | — | -$0.30 | -$0.28 | +6.67% | — | — |
| Q3 2024 Aug 9, 2024 | — | — | — | -$0.28 | -$0.31 | -10.71% | — | — |
| Q2 2024 May 13, 2024 | — | — | — | -$0.34 | -$0.27 | +20.59% | — | — |
| Q1 2024 Mar 11, 2024 | — | — | — | -$0.36 | -$0.25 | +30.56% | — | — |
| Q4 2023 Nov 13, 2023 | — | — | — | -$0.31 | -$0.40 | -29.03% | — | — |
| Q3 2023 Aug 8, 2023 | — | — | — | -$0.24 | -$0.26 | -8.33% | — | — |
| Q2 2023 May 10, 2023 | — | — | — | -$0.20 | -$0.33 | -65.00% | — | — |
| Q1 2023 Mar 31, 2023 | — | — | — | -$0.22 | -$1.04 | -374.40% | — | — |
| Q3 2022 Sep 30, 2022 | — | — | — | — | -$0.10 | — | — | — |
| Q3 2022 Aug 10, 2022 | — | — | — | -$0.23 | -$0.12 | +49.67% | — | — |
| Q2 2022 Apr 29, 2022 | — | — | — | — | -$0.26 | — | — | — |
| Q1 2022 Mar 31, 2022 | — | — | — | — | -$0.05 | — | — | — |
| Q3 2021 Sep 30, 2021 | — | — | — | — | -$0.26 | — | — | — |
| Q2 2021 Jun 30, 2021 | — | — | — | — | -$0.25 | — | — | — |
| Q1 2021 Mar 31, 2021 | — | — | — | — | -$0.25 | — | — | — |